Complications of Cushing's syndrome: state of the art.
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A.
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29. doi: 10.1016/S2213-8587(16)00086-3. Epub 2016 May 10.
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
Dormoy A, Haissaguerre M, Vitellius G, Do Cao C, Geslot A, Drui D, Lasolle H, Vieira-Pinto O, Salenave S, François M, Puerto M, Boullay HD, Mayer A, Rod A, Laurent C, Chanson P, Reznik Y, Castinetti F, Chabre O, Baudin E, Raverot G, Tabarin A, Young J.
J Clin Endocrinol Metab. 2023 May 17;108(6):1475-1487. doi: 10.1210/clinem/dgac691.
Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R, Simeoli C, Di Paola N, Colao A.
Pituitary. 2022 Oct;25(5):726-732. doi: 10.1007/s11102-022-01262-8. Epub 2022 Aug 29.
Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
Torpy DJ, Mullen N, Ilias I, Nieman LK.
Ann N Y Acad Sci. 2002 Sep;970:134-44. doi: 10.1111/j.1749-6632.2002.tb04419.x.
Hypokalemia associated with mifepristone use in the treatment of Cushing's syndrome.
Sai K, Lal A, Lakshmi Maradana J, Velamala PR, Nitin T.
Endocrinol Diabetes Metab Case Rep. 2019 Nov 12;2019:19-0064. doi: 10.1530/EDM-19-0064. Online ahead of print.
Periodic hypokalemia associated with cyclic Cushing's syndrome.
Kikuchi H, Yoshimoto T, Tanaka H, Tsujimoto K, Yamamura C, Arai Y, Hirasawa S, Aki S, Inaba N, Aoyagi M, Ogawa Y, Tamura T.
CEN Case Rep. 2014 May;3(1):80-85. doi: 10.1007/s13730-013-0090-1. Epub 2013 Aug 9.
Adrenal Emergencies.
Bridwell RE, April MD.
Emerg Med Clin North Am. 2023 Nov;41(4):795-808. doi: 10.1016/j.emc.2023.06.006. Epub 2023 Jul 22.
Hypokalemia associated with pseudo-Cushing's syndrome and magnesium deficiency induced by chronic alcohol abuse.
Kurajoh M, Ohsugi K, Kakutani-Hatayama M, Shoji T, Koyama H.
CEN Case Rep. 2018 May;7(1):148-152. doi: 10.1007/s13730-018-0315-4. Epub 2018 Feb 15.
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing's syndrome.
Di Filippo L, Vitali G, Taccagni G, Pedica F, Guaschino G, Bosi E, Martinenghi S.
Endocrine. 2020 Feb;67(2):318-320. doi: 10.1007/s12020-020-02202-x. Epub 2020 Jan 22.
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations.
Brown DR, East HE, Eilerman BS, Gordon MB, King EE, Knecht LA, Salke B, Samson SL, Yuen KCJ, Yau H.
Clin Diabetes Endocrinol. 2020 Oct 29;6(1):18. doi: 10.1186/s40842-020-00105-4.
